STAT

Opinion: Doctors like me are at a loss when parents can’t agree on their child’s treatment

My young patient's condition was worsening, and I knew he needed surgery. But his parents were still at odds on what was best for their son.

Kathy sat quietly before me in one of our pediatric exam rooms, dabbing tears from her eyes. Beside her sat her husband, Mitch, his right hand clenched so hard that his fingers had gone white. Jasper, their 3-month old son, lay swaddled in Kathy’s arms, struggling to breathe, the veins on his tiny neck bulging with each desperate inhalation. (The family’s names have been changed for privacy.)

The silence between Kathy and Mitch was palpable, and it was obvious that they were somehow at odds.

Days after Jasper’s birth, I had diagnosed him with , a congenital condition in which the structures of the voice box become too soft,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks